New: Clinical trial search, funded by the National Cancer Institute
New: NCI-funded clinical trial search
Community
Tools
Company
Support
Sign in
Join for Free
Join for Free
Community
How do you manage a patient on long-term testosterone therapy who develops a hematocrit of 52% but wants to continue treatment?
Is there evidence to support the AUA 50% cut-off?
Good Question
Save
Request Answers
Share
Add Answer
